Vimarsana
Biggest News Aggregation in the World

Page 9 - Acticor Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acticor Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acticor Biotech Today - Breaking & Trending Today

Acticor Biotech: ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of August 31, 2022 - Vimarsana News

Acticor Biotech: ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of August 31, 2022

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, today

Celsion Appoints Dr. Corinne Le Goff as President and Chief - Vimarsana News

Celsion Appoints Dr. Corinne Le Goff as President and Chief

Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:...

Acticor Biotech gets patent for cardiovascular emergency treatment - Vimarsana News

Acticor Biotech gets patent for cardiovascular emergency treatment

Acticor Biotech has announced the EPO has granted a new patent to protect the use of glenzocimab in thrombotic diseases in Europe until 2036.

Acticor Biotech Announces the Issuance of a Patent in Europe for Glenzocimab, Its Innovative Product for the Treatment of Cardiovascular Emergencies - Vimarsana News

Acticor Biotech Announces the Issuance of a Patent in Europe for Glenzocimab, Its Innovative Product for the Treatment of Cardiovascular Emergencies

This patent protects the use of glenzocimab in thrombotic diseases until 2036 This patent has already been granted in the United States and Singapore and is in the process of being granted

Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of May 31, 2022 - Vimarsana News

Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of May 31, 2022

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies